Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
448 Clinical outcomes and safety of immune checkpoint inhibitors (ICI) in patients with solid tumors and paraneoplastic syndromes (PNS)
Compose a Response to This Article
Other responses
No responses have been published for this article.
